Rob Dillard

DocwireNews

Taxus chinensis (TC) has significant therapeutic potential in alleviating non-small cell lung cancer (NSCLC), according to a study <a href="https://pubmed.ncbi.nlm.nih.gov/37933017/">published</a> in the journal Medicine.&nbsp;In this study, investigators used integrated bioinformatics and network pharmacology to examine the potential targets and molecular mechanisms of TC against NSCLC. They designed a protein-protein interaction network, and topological analysis was performed to obtain hub genes. The researchers noted that the expression of the hub genes in NSCLC tissues and their consequent effects on the prognosis of patients with NSCLC were confirmed. Molecular docking was then used to verify the binding affinity between the active ingredients of TC and the hub targets.The analysis uncovered 401 common targets that were significantly enriched in the cancer, MAPK signaling, and PI3K/Akt signaling pathways. Gene hubs included proto-oncogene tyrosine-protein kinase Src (SRC), mitogen-activated protein kinase 1, phosphoinositide-3-kinase, regulatory subunit 1 (PIK3R1), AKT serine/threonine kinase 1 (AKT1), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, and lymphocyte-specific protein tyrosine kinase.Immunohistochemical results confirmed that the expression of SRC, mitogen-activated protein kinase 1, PIK3R1, AKT1, and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha was upregulated in the NSCLC tissues. Moreover, a survival analysis showed that the expression of SRC, AKT1, PIK3R1, and lymphocyte-specific protein tyrosine kinase was closely related to the prognosis of patients with NSCLC.&ldquo;Molecular docking results confirmed all bioactive ingredients present in TC [were] strongly bound to hub targets,&rdquo; the researchers wrote. &ldquo;TC exhibits an anti-NSCLC role through multi-target combination and multi-pathway cooperation,&rdquo; they concluded.

Jordana Jampel

Successful HIV Viral Suppression With At-Home Administration

Modernization and the Rising Burden of IBD: New Insights From a Global Study

Gastroenterology

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Latest News

Study Shows Therapeutic Target, Molecular Mechanisms of Taxus Chinensis in Treating NSCLC

Non-Small Cell Lung Cancer

Taxus chinensis has significant therapeutic potential in alleviating non-small cell lung cancer.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe